Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events: A Meta-Analysis of Randomized Clinical Trials

Objective. Data from randomized clinical trials with metabolic outcomes can be used to address concerns about potential issues of cardiovascular safety for newer drugs for type 2 diabetes. This meta-analysis was designed to assess cardiovascular safety of GLP-1 receptor agonists. Design and Methods....

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Monami, Matteo, Cremasco, Francesco, Lamanna, Caterina, Colombi, Claudia, Desideri, Carla Maria, Iacomelli, Iacopo, Marchionni, Niccolò, Mannucci, Edoardo
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2011
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3092497/
https://ncbi.nlm.nih.gov/pubmed/21584276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/215764
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky